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Structured diabetes education for patients with type 1 diabetes is a cornerstone 
of the therapy. However, it is unclear whether patients with MDI and CSII equally 
benefit from diabetes education. In a prospective analysis, we investigated the 
differential effects of diabetes education on patients with MDI and CSII therapy.
A total of 409 patients with type 1 diabetes that participated in a diabetes educa-
tion course were analyzed. The education course consisted of 12 lessons and was 
conducted as a group program for 3-8 patients. 19% of the patients were treated 
with an insulin pump. Prior to the education course and six months after the end 
of the education course, HbA1c was measured and patients completed question-
naires assessing diabetes distress and hypoglycemia unawareness.
At baseline, patients with CSII therapy did not differ from MDI patients with regard 
to age (43.8 ± 14.0 vs. 44.1 ± 13.6 years, p=.86), gender (47% vs. 42% female, p=.42), 
glycemic control (8.1 ± 1.3 vs. 8.1 ±1.1 %, p=.81), hypoglycemia unawareness (1.6 
± 1.5 vs. 1.7 ±1.8, p=.93), and diabetes distress (1.1 ±0.9 vs. 1.1 ± 10.7, p=.93). 
CSII patients had a significantly longer diabetes duration than MDI patients (22.0 
±10.8 vs. 11.0 ±12.3 years, p<.01). After 6 months, HbA1c reduction was signifi-
cantly lower in CSII patients than in MDI patients (-0.0 ±0.7 vs. -0.4 ±1.1%, p=.01). 
Improvements in hypoglycemia unawareness (0.5 ± 11.4 vs. 0.4 ±1.4, p=.32) and 
diabetes distress (-0.3 ±0.6 vs.-0.2 ±0.6, p=.13) were comparable.
At baseline, glycemic control of CSII patients was not better than that of MDI pa-
tients despite the fact that CSII therapy is the best available therapy option for 
patients with type 1 diabetes. Furthermore, CSII patients did benefit less from di-
abetes education than MDI patients. Specific interventions are needed to address 
the special needs of patients performing a CSII therapy. In a group setting, it can 
be questioned whether CSII and MDI patients should be mixed.
A B S T R A C T
• Structured diabetes education for people  with type 1 diabetes is a 
cornerstone of the therapy. 
• However, it is unclear whether people with type 1 diabetes treated 
by multiple daily insulin injections (MDI) or continuous subcutane-
ous insulin infusion (CSII) will equally benefit from diabetes educa-
tion. 
• In a prospective analysis we investigated the differential effects of 
diabetes education on people with type 1 diabetes either on MDI 
or CSII therapy.
I N T R O D U C T I O N
R E S U L T S
• At baseline patients with CSII therapy did not differ from MDI pa-
tients with regard to age, gender, glycemic control, hypoglycemia 
unawareness diabetes distress, diabetes self-efficacy or empower-
ment (see table 1). 
• The only significant difference at baseline was a longer diabetes du-
ration in people with CSII-therapy compared to people with MDI-
treatment (see table 1). 
• After 6 months HbA1c reduction was significantly lower in CSII pati-
ents than in MDI patients (-0.0 ±0.7 vs. -0.4 ±1.1%, p=.01), whereas 
the improvements in hypoglycemia unawareness was comparable 
(see figure 1). 
• The impact of the structured diabetes education on diabetes dis-
tress and depression (see figure 2) as well as on self-efficacy and 
empowerment was also comparable in subjects with CSII and MDI-
therapy (see figure 2 and 3). 
• In figure 4 effect sizes of the CSII and MDI therapy on the above 
mentioned outcome variables are depicted. Effect sizes were rather 
small or medium. 
C O N C L U S I O N
At baseline, glycemic control of CSII patients was not better than that 
of MDI patients despite the fact that CSII therapy is the best available 
therapy option for patients with type 1 diabetes. Furthermore, CSII 
patients did benefit less from diabetes education than MDI patients 
with regard to glycemic control. Specific interventions are needed to 
address the special needs of patients performing a CSII therapy. In 
a group setting, it can be questioned whether CSII and MDI patients 
should be mixed. Figure 4:  Effect size of diabetes education on different outcomes in CSII and MDI
Figure 2:  Effect of MDI- und CSII- therapy on diabetes distress (left) and depression (right)
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Table 1:  Sample characteristics
Figure 3:  Effect of MDI- und CSII- therapy on self-efficacy (left) and empowerment (right)
Figure 1:  Effect of MDI and CSII – therapy on HbA1c (left) and hypoglycemia-unawareness 
(right)
M E T H O D S
A total of 409 patients with type 1 diabetes that participated in a dia-
betes education course were analyzed. 
• The education course consisted of 12 lessons and was conducted 
as a group program for 3-8 patients. 
• 19% of the patients were treated with an insulin pump. Prior to 
the education course and six months after the end of the educa-
tion course, HbA1c was measured and patients completed questi-
onnaires assessing diabetes distress:
o (Diabetes Distress Scale - DDS)
o Hypoglycemia unawareness (Hypoglycemia unawareness 
Questionnaire -HUQ) 
o Depression (Center of Epidemiological Studies Depression 
Scale – CES-D)
o Diabetes self-efficacy (Diabetes Self-Efficacy Scale)
o Empowerment (Empowerment Scale) 
• Cohen´s d was used as a measure of effect size.
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